PRELUDE CAPITAL MANAGEMENT, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$24,998
-98.4%
12,562
-96.3%
0.00%
-97.4%
Q4 2020$1,547,000
+45.5%
338,426
+23.5%
0.04%
-23.5%
Q3 2020$1,063,000
+57.5%
273,972
+93.2%
0.05%
+37.8%
Q2 2020$675,000
-10.6%
141,842
-34.6%
0.04%
-27.5%
Q1 2020$755,000
+8288.9%
216,842
+16580.2%
0.05%
Q2 2019$9,000
-59.1%
1,300
-3.1%
0.00%
-100.0%
Q2 2018$22,0001,3410.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders